ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,161Medicare Part D Prescriptions Filled, Including Refills

Rank: 211 out of 3734

$812K Total Retail Price of All Prescriptions

Rank: 204 out of 3734

813 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 12,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 662 576 1 1
OMEPRAZOLE 544 457 2 4
LEVOTHYROXINE SODIUM 508 420 3 2
LISINOPRIL 467 455 4 3
AMLODIPINE BESYLATE 393 367 5 5
HYDROCHLOROTHIAZIDE 359 348 6 9
METFORMIN HCL 334 270 7 8
ATORVASTATIN CALCIUM 330 296 8 11
PRAVASTATIN SODIUM 322 290 9 15
METOPROLOL TARTRATE 204 198 10 6
ALENDRONATE SODIUM 202 185 11 26
LOSARTAN POTASSIUM 200 188 12 21
ATENOLOL 191 189 13 13
WARFARIN SODIUM 182 155 14 10
HYDROCODONE-ACETAMINOPHEN 175 139 S3 15 12
CRESTOR 172 161 16 28
METOPROLOL SUCCINATE 164 162 17 14
CITALOPRAM HBR 161 137 18 16
DONEPEZIL HCL 161 149 18 25
GABAPENTIN 149 134 20 17
DIOVAN 148 147 21 31
SYNTHROID 148 143 21 47
ZOLPIDEM TARTRATE 146 141 23 24
AZITHROMYCIN 139 124 24 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 120 25 27
FUROSEMIDE 134 122 26 7
JANTOVEN 131 130 27 76
FLUTICASONE PROPIONATE 111 98 28 46
POTASSIUM CHLORIDE 109 103 29 19
GLIMEPIRIDE 109 101 29 37
CARVEDILOL 109 99 29 30
SERTRALINE HCL 105 77 32 18
ALLOPURINOL 103 99 33 33
TAMSULOSIN HCL 102 96 34 29
NEXIUM 99 99 35 36
JANUVIA 91 86 36 50
TRIAMTERENE-HCTZ 87 72 37 73
LIPITOR 86 86 38 90
PANTOPRAZOLE SODIUM 85 84 39 22
CLOPIDOGREL 84 78 40 23
LOSARTAN-HYDROCHLOROTHIAZIDE 83 80 41 71
BENICAR 82 70 42 107
ACTOS 80 65 43 110
FAMOTIDINE 79 78 44 60
TRAZODONE HCL 72 38 45 49
MIRTAZAPINE 72 58 45 45
ISOSORBIDE MONONITRATE ER 70 69 47 34
RAMIPRIL 69 68 48 91
BUMETANIDE 69 68 48 78
PLAVIX 69 69 48 39
NAPROXEN 68 41 51 101
TRAMADOL HCL 68 63 51 20
CARBIDOPA-LEVODOPA 68 66 51 92
AMLODIPINE BESYLATE-BENAZEPRIL 67 65 54 56
ADVAIR DISKUS 65 62 55 35
DIOVAN HCT 63 63 56 72
BENICAR HCT 63 63 56 167
CYCLOBENZAPRINE HCL 59 46 R 58 87
FLUOXETINE HCL 59 34 58 61
VYTORIN 58 58 60 163
BENAZEPRIL HCL 58 58 60 103
KLOR-CON M20 57 54 62 48
BETAMETHASONE DIPROPIONATE 57 50 62 285
CEPHALEXIN 56 48 64 120
VENLAFAXINE HCL ER 56 38 64 84
GLIPIZIDE XL 55 52 66 85
OXYBUTYNIN CHLORIDE ER 53 51 67 141
CELEBREX 52 46 68 69
ACTONEL 51 38 69 188
CEFUROXIME 51 43 69 168
LANTUS 51 51 69 54
QUETIAPINE FUMARATE 51 26 69 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.